Taipei, Taiwan

Chinpan Chen

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chinpan Chen. Retrieved from https://idiyas.com/inventor/chinpan-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chinpan Chen in Bacterial Signal Transduction

Introduction

Chinpan Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of microbiology, particularly in the development of inhibitors for bacterial signal transduction systems. His work is crucial in addressing the challenges posed by multi-drug resistant bacteria.

Latest Patents

Chinpan Chen holds a patent for "Inhibitors of bacterial two component signal transduction system and uses thereof." This patent discloses novel uses of a compound of formula (I) as an inhibitor of bacterial two-component signal transduction systems. The compound may suppress or inhibit the growth of bacteria, including notorious multi-drug resistant strains. He has 1 patent to his name.

Career Highlights

Chinpan Chen is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to focus on innovative research that has the potential to impact public health significantly.

Collaborations

Chinpan Chen collaborates with esteemed colleagues such as Tien-Sheng Tseng and Keng-Chang Tsai. Their combined expertise enhances the research efforts in the field of bacterial signal transduction.

Conclusion

Chinpan Chen's innovative work in developing inhibitors for bacterial signal transduction systems showcases his commitment to addressing critical health issues. His contributions are vital in the ongoing battle against antibiotic resistance.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…